THE BROAD INSTITUTE, INC
- CAMBRIDGE, MA 02142-1027
- Corporate Entity (Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $12.8M
- Awards on record
- 17
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
THE BROAD INSTITUTE, INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About THE BROAD INSTITUTE, INC
- Headquarters
- CAMBRIDGE, MA 02142-1027
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIH5G9NWEFHXN4
- CAGE5BP51
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $12.8M
- Awards on record
- 17
- Top funding agencies
- Centers for Disease Control and Prevention · National Institutes of Health · Department of Veterans Affairs
Awards
75N98026P01944
Recompete 6–12 mo: Potential end Sep 28, 2027 (10 months away)NIA - WHOLE GENOME SEQUENCING - NON-SEVERABLE
Department of Health and Human Services · National Institutes of Health
- Obligated
- $215.1K
- Period of performance
- Sep 29, 2026 – Sep 28, 2027
75N98026P01702
Recompete 6–12 mo: Potential end Sep 16, 2027 (10 months away)BROAD INSTITUTE, INC., THE:1157729 [26-003213] 5-BASE SAMPLE PREP AND WHOLE GENOME MULTIOMIC PROFILING
Department of Health and Human Services · National Institutes of Health
- Obligated
- $140K
- Period of performance
- Sep 17, 2026 – Sep 16, 2027
36C24E26N0145
Recompete 6–12 mo: Potential end Jun 7, 2027 (6 months away)PROSTATE CANCER-SPECIFIC SEQUENCING SERVICES (RESEARCH STUDY SUPPORT)
Department of Veterans Affairs
- Obligated
- $65K
- Period of performance
- Jun 8, 2026 – Jun 7, 2027
75N98026P00649
Recompete 6–12 mo: Potential end Jun 4, 2027 (6 months away)NHLBI: SERVICE: WHOLE GENOME SEQUENCING OF SICKLE CELL PATIENT BLOOD SAMPLES: SEVERABLE
Department of Health and Human Services · National Institutes of Health
- Obligated
- $156.3K
- Period of performance
- Jun 5, 2026 – Jun 4, 2027
75D30124C20246
Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)RESEARCH AND DEVELOPMENT SERVICES
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $1M
- Period of performance
- Sep 27, 2024 – Mar 31, 2027
75D30123C17983
Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)DEMONSTRATING PAN-PATHOGEN AND PATHOGEN-AGNOSTIC GENOMIC SURVEILLANCE OF CLINICAL RESPIRATORY DISEASE
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $4.6M
- Period of performance
- Sep 29, 2023 – Mar 31, 2027
75N95022C00042
Completed: Period of performance ended Sep 29, 2026GENETIC TESTING (HUMAN GENOME SEQUENCING) AND DATA ANALYSIS SERVICES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $193.9K
- Period of performance
- Sep 30, 2022 – Sep 29, 2026
75N92023P00384
Completed: Period of performance ended Sep 21, 2025WHOLE GENOME SEQUENCING OF SICKLE CELL PATIENT BLOOD SAMPLES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $202.5K
- Period of performance
- Sep 22, 2023 – Sep 21, 2025
75N95024P00355
Completed: Period of performance ended Jun 30, 2025PROCODE-BASED STRATEGIES FOR LARGE-SCALE IMAGING OF IPSCS AND IPSC-DERIVED CELL TYPES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $241.6K
- Period of performance
- Jul 1, 2024 – Jun 30, 2025
75D30122C14365
Completed: Period of performance ended Mar 25, 2025FY22 BAA TOPIC 7 - THE BROAD INSTITUTE
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $2.2M
- Period of performance
- Sep 26, 2022 – Mar 25, 2025
75D30122C15113
Completed: Period of performance ended Jul 31, 2024BAA TOPIC 20.1 - ADVANCING CRISPR BASED DIAGNOSTICS IN RESPONSE TO ONGOING PATHOGENIC THREATS
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $3.7M
- Period of performance
- Aug 26, 2022 – Jul 31, 2024
75N92021P00225
Completed: Period of performance ended Jul 6, 2023WHOLE GENOME SEQUENCING OF SICKLE CELL DISEASE SAMPLES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $161.3K
- Period of performance
- Jul 7, 2021 – Jul 6, 2023
75N95021P00715
Completed: Period of performance ended Sep 28, 2022WHOLE EXOME SEQUENCING, WHOLE GENOME SEQUENCING, RNA SEQUENCING AND ACCESS TO DATA THROUGH AN ANALYSIS PLATFORM SEQR.
Department of Health and Human Services · National Institutes of Health
- Obligated
- $28.7K
- Period of performance
- Sep 28, 2021 – Sep 28, 2022
75D30121C10501
Completed: Period of performance ended Mar 11, 2022SARS-COV-2 GENOMIC SEQUENCING
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $15.8M
- Period of performance
- Mar 12, 2021 – Mar 11, 2022
HHSN268201600034I-HHSN26800003
Completed: Period of performance ended Sep 28, 2021IGF::OT::IGF - SEQUENCING SERVICES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $22.4M
- Period of performance
- Sep 27, 2017 – Sep 28, 2021
75N92018F00004
Completed: Period of performance ended Sep 23, 2021IGF::OT::IGF
Department of Health and Human Services · National Institutes of Health
- Obligated
- $5.1M
- Period of performance
- Sep 21, 2018 – Sep 23, 2021
HHSN268201000029C
Completed: Period of performance ended Oct 30, 2017TAS::75 0872::TAS LABORATORY, DATA ANALYSIS, AND COORDINATING CENTER (LDACC) FOR THE GENOTYPE-TISSUE EXPRESSION (GTEX) PROJECT - A NIH…
Department of Health and Human Services · National Institutes of Health
- Obligated
- $56.1M
- Period of performance
- Jul 30, 2010 – Oct 30, 2017
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N98026P01944 NIA - WHOLE GENOME SEQUENCING - NON-SEVERABLE | Department of Health and Human Services · National Institutes of Health | 541714 · Q301REFERENCE LABORATORY TESTING | $215.1K | Sep 29, 2026 – Sep 28, 2027 | Recompete 6–12 mo: Potential end Sep 28, 2027 (10 months away)AI brief for award 75N98026P01944Bid team for the recompete of award 75N98026P01944 |
75N98026P01702 BROAD INSTITUTE, INC., THE:1157729 [26-003213] 5-BASE SAMPLE PREP AND WHOLE GENOME MULTIOMIC PROFILING | Department of Health and Human Services · National Institutes of Health | 541714 · Q301REFERENCE LABORATORY TESTING | $140K | Sep 17, 2026 – Sep 16, 2027 | Recompete 6–12 mo: Potential end Sep 16, 2027 (10 months away)AI brief for award 75N98026P01702Bid team for the recompete of award 75N98026P01702 |
36C24E26N0145 under 36C24E26D0017 PROSTATE CANCER-SPECIFIC SEQUENCING SERVICES (RESEARCH STUDY SUPPORT) | Department of Veterans Affairs | 541714 · B529SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $65K | Jun 8, 2026 – Jun 7, 2027 | Recompete 6–12 mo: Potential end Jun 7, 2027 (6 months away)AI brief for award 36C24E26N0145Bid team for the recompete of award 36C24E26N0145 |
75N98026P00649 NHLBI: SERVICE: WHOLE GENOME SEQUENCING OF SICKLE CELL PATIENT BLOOD SAMPLES: SEVERABLE | Department of Health and Human Services · National Institutes of Health | 541990 · Q301REFERENCE LABORATORY TESTING | $156.3K | Jun 5, 2026 – Jun 4, 2027 | Recompete 6–12 mo: Potential end Jun 4, 2027 (6 months away)AI brief for award 75N98026P00649Bid team for the recompete of award 75N98026P00649 |
75D30124C20246 RESEARCH AND DEVELOPMENT SERVICES | Department of Health and Human Services · Centers for Disease Control and Prevention | 541715 · AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH | $1M | Sep 27, 2024 – Mar 31, 2027 | Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)AI brief for award 75D30124C20246Bid team for the recompete of award 75D30124C20246 |
75D30123C17983 DEMONSTRATING PAN-PATHOGEN AND PATHOGEN-AGNOSTIC GENOMIC SURVEILLANCE OF CLINICAL RESPIRATORY DISEASE | Department of Health and Human Services · Centers for Disease Control and Prevention | 541714 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $4.6M | Sep 29, 2023 – Mar 31, 2027 | Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)AI brief for award 75D30123C17983Bid team for the recompete of award 75D30123C17983 |
75N95022C00042 GENETIC TESTING (HUMAN GENOME SEQUENCING) AND DATA ANALYSIS SERVICES | Department of Health and Human Services · National Institutes of Health | 621511 · R499SUPPORT- PROFESSIONAL: OTHER | $193.9K | Sep 30, 2022 – Sep 29, 2026 | Completed: Period of performance ended Sep 29, 2026 |
75N92023P00384 WHOLE GENOME SEQUENCING OF SICKLE CELL PATIENT BLOOD SAMPLES | Department of Health and Human Services · National Institutes of Health | 541990 · Q301REFERENCE LABORATORY TESTING | $202.5K | Sep 22, 2023 – Sep 21, 2025 | Completed: Period of performance ended Sep 21, 2025 |
75N95024P00355 PROCODE-BASED STRATEGIES FOR LARGE-SCALE IMAGING OF IPSCS AND IPSC-DERIVED CELL TYPES | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $241.6K | Jul 1, 2024 – Jun 30, 2025 | Completed: Period of performance ended Jun 30, 2025 |
75D30122C14365 FY22 BAA TOPIC 7 - THE BROAD INSTITUTE | Department of Health and Human Services · Centers for Disease Control and Prevention | 541715 · AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH | $2.2M | Sep 26, 2022 – Mar 25, 2025 | Completed: Period of performance ended Mar 25, 2025 |
75D30122C15113 BAA TOPIC 20.1 - ADVANCING CRISPR BASED DIAGNOSTICS IN RESPONSE TO ONGOING PATHOGENIC THREATS | Department of Health and Human Services · Centers for Disease Control and Prevention | 541715 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $3.7M | Aug 26, 2022 – Jul 31, 2024 | Completed: Period of performance ended Jul 31, 2024 |
75N92021P00225 WHOLE GENOME SEQUENCING OF SICKLE CELL DISEASE SAMPLES | Department of Health and Human Services · National Institutes of Health | 621511 · Q301REFERENCE LABORATORY TESTING | $161.3K | Jul 7, 2021 – Jul 6, 2023 | Completed: Period of performance ended Jul 6, 2023 |
75N95021P00715 WHOLE EXOME SEQUENCING, WHOLE GENOME SEQUENCING, RNA SEQUENCING AND ACCESS TO DATA THROUGH AN ANALYSIS PLATFORM SEQR. | Department of Health and Human Services · National Institutes of Health | 621511 · Q301REFERENCE LABORATORY TESTING | $28.7K | Sep 28, 2021 – Sep 28, 2022 | Completed: Period of performance ended Sep 28, 2022 |
75D30121C10501 SARS-COV-2 GENOMIC SEQUENCING | Department of Health and Human Services · Centers for Disease Control and Prevention | 621511 · Q301REFERENCE LABORATORY TESTING | $15.8M | Mar 12, 2021 – Mar 11, 2022 | Completed: Period of performance ended Mar 11, 2022 |
HHSN268201600034I-HHSN26800003 under HHSN268201600034I IGF::OT::IGF - SEQUENCING SERVICES | Department of Health and Human Services · National Institutes of Health | 541380 · B599SPECIAL STUDIES/ANALYSIS- OTHER | $22.4M | Sep 27, 2017 – Sep 28, 2021 | Completed: Period of performance ended Sep 28, 2021 |
75N92018F00004 under HHSN268201600034I IGF::OT::IGF | Department of Health and Human Services · National Institutes of Health | 541380 · B599SPECIAL STUDIES/ANALYSIS- OTHER | $5.1M | Sep 21, 2018 – Sep 23, 2021 | Completed: Period of performance ended Sep 23, 2021 |
HHSN268201000029C TAS::75 0872::TAS LABORATORY, DATA ANALYSIS, AND COORDINATING CENTER (LDACC) FOR THE GENOTYPE-TISSUE EXPRESSION (GTEX) PROJECT - A NIH… | Department of Health and Human Services · National Institutes of Health | 541712 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $56.1M | Jul 30, 2010 – Oct 30, 2017 | Completed: Period of performance ended Oct 30, 2017 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
Terra
FedRAMP Authorized (Moderate)
Authorized: a federal agency or the FedRAMP Board approved this cloud service for government use.
- Authorized
- May 7, 2021
- Agency authorizations
- 2 (National Cancer Institute, National Institutes of Health)
- Service model
- PaaS
- Assessor (3PAO)
- Coalfire Systems, Inc.
- Last seen on the Marketplace
- Nov 13, 2026
Source: FedRAMP Marketplace (opens in a new tab) · as of Nov 13, 2026
Exclusions & screening
SAM.gov exclusions
No active exclusion on record (checked Nov 14, 2026).
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · as of Nov 14, 2026
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 14, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 14, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with THE BROAD INSTITUTE, INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
